Sign in

CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Bicara Therapeutics Inc.

Sign in to watch
Ticker
BCAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-468-4219
Business address
116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. 144 Insider Sale of Securities
  7. 144 Insider Sale of Securities
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 4 Planned sale Chief Executive Officer sold 24,103 shares at $18.83 ($453,761)
  11. 4 Planned sale President and COO sold 12,500 shares at $18.16 ($226,943)
  12. 144 Insider Sale of Securities
  13. 4 Planned sale Chief Executive Officer sold 24,734 shares at an average $18.88 ($466,936)
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 4 Planned sale Chief Medical Officer sold 22,000 shares at $18.45 ($405,900)
  18. 4 Planned sale Chief Financial Officer sold 6,415 shares at $18.23 ($116,931)
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 8 of 14 · 266 filings